Is RADNOSTIX, INC. halal to invest in?

According to Musaffa's Shariah screening methodology, RADNOSTIX, INC. (INIS) is currently classified as HALAL as of July 2024. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is RADNOSTIX, INC. a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes RADNOSTIX, INC. using these criteria to determine its compliance status.

Can Muslims buy shares of RADNOSTIX, INC.?

Muslim investors may consider investing in RADNOSTIX, INC. if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is RADNOSTIX, INC. classified as HALAL?

Musaffa determines the Shariah status of RADNOSTIX, INC. by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for RADNOSTIX, INC. updated?

The Shariah compliance status of RADNOSTIX, INC. may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like RADNOSTIX, INC. become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of RADNOSTIX, INC.?

You can check the latest Shariah compliance status of RADNOSTIX, INC. on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

INIS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: July 31, 2024

Report Source: 2024 1st Quarter Report

RADNOSTIX, INC.. Stock Analysis INIS

United States Health Care Nano Cap Report: Q1, 2024

Radnostix, Inc. engages in the manufacture of nuclear medicine calibration and reference standards cobalt tele therapy sources, as well as radioisotopes and radiochemical for medical research and clinical devices. The company is headquartered in Idaho Falls, Idaho and currently employs 44 full-time employees. The firm manufactures and supplies generic sodium iodide I-131 radio-pharmaceutical drug product for hyperthyroidism and thyroid cancer. The firm provides contract manufacturing of various drug products as well as radioisotope active pharmaceutical ingredient (API) supply for third party theranostics clients. The firm manufactures and distributes a complete line of calibration and reference standards for nuclear pharmacies and single photon emission computed tomography (SPECT)/positron emission tomography (PET) imaging systems as well as industrial calibration standards under its RadQual brand. The firm also manufactures Cobalt-60 sealed source products.

Key Statistics of RADNOSTIX, INC. (INIS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.09$0.09

Today's Open

$0.09

Volume

5813.00

P/E Ratio (TTM)

52 Week Range

$0.04$0.11

Market Cap

39.68M

Avg. Volume

105.93K

Dividend Yield

Financial Metrics & Statements of RADNOSTIX, INC. (INIS)

FAQ's for RADNOSTIX, INC. (INIS)

According to Musaffa’s Shariah screening methodology, RADNOSTIX, INC. (INIS) is currently classified as HALAL as of July 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.